Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: e1cb474d4cd6c88270057a0ccf33cf7f

Number

Shortcode

Scope

Section

Description

100AboutDRCBBAbout this ReportSection for data identification purposes
101GeneralDRCBBGeneral HLA typed and listed unrelated donor/CBU/ADCU dataSection for gaining statistics and insight into current global unrelated donor/CBU/ADCU inventory for transplantation
105New DeleteDRHLA typed unrelated donors/CBUs/ADCUs newly listed and permanently deleted by your organisationSection for gaining statistics and insight into growth of global unrelated donor/CBU/ADCU inventory for transplantation and reasons for permanent deletion of already previously listed unrelated donor/CBU/ADCU.
110Age SexDRAge and biological sex of HLA typed unrelated donors listed by your organisationSection for tracking demographics of current global unrelated donor inventory for transplantation
130Prospective typingDRCBBProspective typing strategy and strategy to improve typing of your existing HLA typed and previously listed unrelated donors/CBUsSection for gaining insight into current prospective HLA typing strategies and global efforts to improve HLA typing of previously listed unrelated donor/CBU inventory for transplantation
140HACDRHealth and availability check (HAC) for your HLA typed and listed unrelated donors (prior to/without collection of blood sample for extended typing)Section for tracking development and use of new methods during ET/VT and /WU for unrelated donor
150ETDRExtended typing (ET) requests completed from your HLA typed and listed unrelated donorsSection for tracking development, use and time required of ET for unrelated donor
170VTDRBlood samples requests provided from your HLA typed and listed unrelated donors for verification typing (VT)Section for tracking development, time required and cancellation reasons of VT for unrelated donor. Please note that the answers in this section are used to calculate your KPIs
180WUDRWork-up (WU) requested from your HLA typed and listed unrelated donorsSection for tracking development of unrelated donor WU and their reasons for cancellation. Please note that the answers in this section are used to calculate your KPIs
190CBU ET/VTCBBVerification typings (VT) and extended typings (ET) of your HLA typed and listed unrelated CBUsSection for tracking development, time required and cancellation reasons of ET and VT for unrelated CBU
200CBU shippedCBBCBUs shipped by your organisation for unrelated patientsSection for tracking global statistics on unrelated CBU shipments and reasons for not transplanting
220CBU pediatricCBBCBUs shipped for unrelated pediatric patients (16 years or below)Section for tracking global development of unrelated CBU use in pediatric patients per transplant type
240CBU adultsCBBCBUs shipped for unrelated adult patients (over 16 years)Section for tracking global development of unrelated CBU use in adult patients per transplant type
260CBU cancelCBBCancellations of CBUs orderedSection for tracking global statistics of reasons for CBU cancellation after ordering
280CBU TNCCBBPost-processing, pre-freezing total nucleated cell (TNC) count of unrelated CBUs provided for transplantationSection for gaining insight into TNC counts of unrelated CBU used for transplantation, which may be used for CBU banking policies
500ADCU VTDRVerification typings (VT) of your ADCUsSection for tracking global statistics of VT for unrelated ADCU
510ADCU shippedDRADCUs shipped by your organisation for unrelated patientsSection for tracking global statistics on unrelated ADCU shipments and reasons for not transplanting
530ADCU cancelDRCancellations of ADCUs orderedSection for tracking global statistics of reasons for ADCU cancellation after ordering
550ADCU CD34DRPost-processing, pre-freezing CD34+ absolute count of unrelated ADCU provided for transplantationSection for gaining insight into CD34+ counts of unrelated ADCU used for transplantation, which may be used for ADCU banking policies
600HPC shippedDRCBBDistribution of unrelated HPC/MNC donor products shippedSection for gaining insight into global exchange of unrelated HPC/MNC donor products and calculating import/export and self-sufficiency ratios of countries and individual organisations.
610HPC importDRCBBDistribution of unrelated HPC/MNC donor products importedSection for gaining insight into global exchange of unrelated HPC/MNC donor products and calculating import/export and self-sufficiency ratios of countries and individual organisations.
620First SubsequentDRCBBUnrelated HPC/MNC donations provided by your organisation for first and subsequent donationsSection for tracking development of unrelated HPC/MNC donations for first and subsequent donation
630Unrelated patientsDRCBBPatients received unrelated transplantSection for gaining global statistics on unrelated transplantation
700No registryDRCBBPatients received unrelated transplant in country without national registrySection for gaining insight into facilitation of unrelated transplants in underserved regions
750Related patientsDRCBBPatients received related transplantSection for gaining insight into facilitation of related transplantation by unrelated donor organisations
810HLA DiscrepanciesDRCBBHLA Discrepancies in unrelated donors/CBU (do not include patients or related donors)Section for tracking development of HLA discrepancies in unrelated donor/CBU HLA typing. Please note that the answers in this section are used to calculate your KPIs
820OBDRWork-ups (WU) requested from your unrelated donors for Peripheral Blood Stem Cells (PBSC, HPC, Apheresis) collections onlySection for gaining insight into global apheresis center availability (Orca Bio sponsored question)